iVeena Delivery Systems Inc.

About iVeena Delivery Systems Inc.

iVeena Delivery Systems, Inc. is a privately held, clinical stage ophthalmology company focused on developing disease-modifying pharmacologic innovations for refractive diseases such as keratoconus and myopia.

Products & Services

IVMED-80:An eye drop for keratoconus, licensed to Glaukos Corporation, with Orphan Drug Designation.

IVMED-85:A first-in-class investigational eyedrop formulation for pediatric myopia.

Specialties

Disease-modifying pharmacologic innovations Refractive disease treatments Pediatric myopia Keratoconus

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 2000000 MR: - FA: $2 million FAN: 2000000	D: 2025-09-18 FD: 2025-09-18	1 investors
2	RT: Series B-2 T: - FT: Series B-2	A: 3000000 MR: - FA: 3 million FAN: 3000000	D: 2025-02-05 FD: 2025-02-05	-
3	RT: National Eye Institute Phase 1 Small Business Innovative Research (SBIR) Grant T: - FT: National Eye Institute Phase 1 Small Business Innovative Research (SBIR) Grant	A: 345000 MR: - FA: $345,000 FAN: 345000	D: 2023-10-26 FD: 2023-10-26	1 investors

Grant Latest

2025-09-18

$2.0M

1 investor (Pro only)

Series B-2 2025-02-05

$3.0M

National Eye Institute Phase 1 Small Business Innovative Research (SBIR) Grant 2023-10-26

$345K

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Robert Dempsey

Chairman of the Board, Interim-CEO

B

Balamurali Ambati

President, Founder, Director

N

Ned Weinshenker

Chief Operations Officer & Director

M

Michael Burr

Vice President, Product Development

S

Sarah Molokhia

Vice President, Research & Development

J

Jill Tierney

VP, Finance

View 14 more team members with Pro

Unlock Full Team Directory

Recent News